Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dermot G Neely

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 14, 2007
Hepatic surgery-related hypophosphatemiaHarish K Datta, Mahdi Malik, R Dermot G Neely
Clinics and Research in Hepatology and Gastroenterology|September 11, 2012
Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)David A Sheridan, R Dermot G Neely, Margaret F Bassendine
Journal of Clinical Lipidology|February 28, 2024
Lipoprotein(a) testing in lipid clinics across the UK: Results of a national surveySaleem Ansari, R Dermot G Neely, Jules Payne, et al.
Journal of Thrombosis and Thrombolysis|April 21, 2016
PCSK9 inhibitors in the prevention of cardiovascular diseaseJames Latimer, Jonathan A Batty, R Dermot G Neely, et al.
Annals of Clinical Biochemistry|October 12, 2020
Lp(a): When and how to measure itJaimini Cegla, Michael France, Santica M Marcovina, et al.
Annals of Clinical Biochemistry|May 17, 2008
Lipid external quality assessment: commutability between external quality assessment and clinical specimensRobert Cramb, Jane French, Michael Mackness, et al.
BMJ Open|August 25, 2016
Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational studyVijay Kunadian, R Dermot G Neely, Hannah Sinclair, et al.
Journal of Hepatology|July 2, 2011
HCV and the hepatic lipid pathway as a potential treatment targetMargaret F Bassendine, David A Sheridan, Daniel J Felmlee, et al.
European Journal of Preventive Cardiology|January 22, 2024
Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future researchPia R Kamstrup, R Dermot G Neely, Steven Nissen, et al.
Atherosclerosis|March 16, 2022
How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?Alberico L Catapano, Magdalena Daccord, Elaine Damato, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 14, 2007
Hepatic surgery-related hypophosphatemiaHarish K Datta, Mahdi Malik, R Dermot G Neely
Clinics and Research in Hepatology and Gastroenterology|September 11, 2012
Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)David A Sheridan, R Dermot G Neely, Margaret F Bassendine
Journal of Clinical Lipidology|February 28, 2024
Lipoprotein(a) testing in lipid clinics across the UK: Results of a national surveySaleem Ansari, R Dermot G Neely, Jules Payne, et al.
Journal of Thrombosis and Thrombolysis|April 21, 2016
PCSK9 inhibitors in the prevention of cardiovascular diseaseJames Latimer, Jonathan A Batty, R Dermot G Neely, et al.
Annals of Clinical Biochemistry|October 12, 2020
Lp(a): When and how to measure itJaimini Cegla, Michael France, Santica M Marcovina, et al.
Annals of Clinical Biochemistry|May 17, 2008
Lipid external quality assessment: commutability between external quality assessment and clinical specimensRobert Cramb, Jane French, Michael Mackness, et al.
BMJ Open|August 25, 2016
Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational studyVijay Kunadian, R Dermot G Neely, Hannah Sinclair, et al.
Journal of Hepatology|July 2, 2011
HCV and the hepatic lipid pathway as a potential treatment targetMargaret F Bassendine, David A Sheridan, Daniel J Felmlee, et al.
European Journal of Preventive Cardiology|January 22, 2024
Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future researchPia R Kamstrup, R Dermot G Neely, Steven Nissen, et al.
Atherosclerosis|March 16, 2022
How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?Alberico L Catapano, Magdalena Daccord, Elaine Damato, et al.
Pageof 3